Tadasuke. Komori, et.al., Deficiency of oncostatin M receptor β (OSMRβ) exacerbates high-fat diet-induced obesity and related metabolic disorders in mice., The Journal of biological chemistry, 2014, 289

http://rdf.ncbi.nlm.nih.gov/pubmed/24695736

Tadasuke. Komori, et.al., Deficiency of oncostatin M receptor β (OSMRβ) exacerbates high-fat diet-induced obesity and related metabolic disorders in mice., The Journal of biological chemistry, 2014, 289

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased circulating leptin level_Osmr<tm1Mtan>/Osmr<tm1Mtan>
  http://metadb.riken.jp/0005669B6129SOsmrtm1MtanOsmrtm1MtanOsmrtm1MtanOsmrtm1Mtan
• increased epididymal fat pad weight_Osmr<tm1Mtan>/Osmr<tm1Mtan>
  http://metadb.riken.jp/0009288B6129SOsmrtm1MtanOsmrtm1MtanOsmrtm1MtanOsmrtm1Mtan
• decreased liver glycogen level_Osmr<tm1Mtan>/Osmr<tm1Mtan>
  http://metadb.riken.jp/0010398B6129SOsmrtm1MtanOsmrtm1MtanOsmrtm1MtanOsmrtm1Mtan
• increased susceptibility to diet-induced obesity_Osmr<tm1Mtan>/Osmr<tm1Mtan>
  http://metadb.riken.jp/0005658B6129SOsmrtm1MtanOsmrtm1MtanOsmrtm1MtanOsmrtm1Mtan
• increased circulating insulin level_Osmr<tm1Mtan>/Osmr<tm1Mtan>
  http://metadb.riken.jp/0002079B6129SOsmrtm1MtanOsmrtm1MtanOsmrtm1MtanOsmrtm1Mtan
• increased circulating cholesterol level_Osmr<tm1Mtan>/Osmr<tm1Mtan>
  http://metadb.riken.jp/0005178B6129SOsmrtm1MtanOsmrtm1MtanOsmrtm1MtanOsmrtm1Mtan
• increased food intake_Osmr<tm1Mtan>/Osmr<tm1Mtan>
  http://metadb.riken.jp/0011939B6129SOsmrtm1MtanOsmrtm1MtanOsmrtm1MtanOsmrtm1Mtan
• increased liver weight_Osmr<tm1Mtan>/Osmr<tm1Mtan>
  http://metadb.riken.jp/0002981B6129SOsmrtm1MtanOsmrtm1MtanOsmrtm1MtanOsmrtm1Mtan
• increased liver triglyceride level_Osmr<tm1Mtan>/Osmr<tm1Mtan>
  http://metadb.riken.jp/0009355B6129SOsmrtm1MtanOsmrtm1MtanOsmrtm1MtanOsmrtm1Mtan
• increased pancreatic beta cell number_Osmr<tm1Mtan>/Osmr<tm1Mtan>
  http://metadb.riken.jp/0003645B6129SOsmrtm1MtanOsmrtm1MtanOsmrtm1MtanOsmrtm1Mtan
• increased subcutaneous adipose tissue amount_Osmr<tm1Mtan>/Osmr<tm1Mtan>
  http://metadb.riken.jp/0010934B6129SOsmrtm1MtanOsmrtm1MtanOsmrtm1MtanOsmrtm1Mtan
• increased circulating tumor necrosis factor level_Osmr<tm1Mtan>/Osmr<tm1Mtan>
  http://metadb.riken.jp/0008553B6129SOsmrtm1MtanOsmrtm1MtanOsmrtm1MtanOsmrtm1Mtan
• increased circulating triglyceride level_Osmr<tm1Mtan>/Osmr<tm1Mtan>
  http://metadb.riken.jp/0001552B6129SOsmrtm1MtanOsmrtm1MtanOsmrtm1MtanOsmrtm1Mtan
• hepatic steatosis_Osmr<tm1Mtan>/Osmr<tm1Mtan>
  http://metadb.riken.jp/0002628B6129SOsmrtm1MtanOsmrtm1MtanOsmrtm1MtanOsmrtm1Mtan
• increased liver cholesterol level_Osmr<tm1Mtan>/Osmr<tm1Mtan>
  http://metadb.riken.jp/0010027B6129SOsmrtm1MtanOsmrtm1MtanOsmrtm1MtanOsmrtm1Mtan
• increased circulating glucose level_Osmr<tm1Mtan>/Osmr<tm1Mtan>
  http://metadb.riken.jp/0005559B6129SOsmrtm1MtanOsmrtm1MtanOsmrtm1MtanOsmrtm1Mtan
• increased circulating interleukin-10 level_Osmr<tm1Mtan>/Osmr<tm1Mtan>
  http://metadb.riken.jp/0008593B6129SOsmrtm1MtanOsmrtm1MtanOsmrtm1MtanOsmrtm1Mtan
• increased inflammatory response_Osmr<tm1Mtan>/Osmr<tm1Mtan>
  http://metadb.riken.jp/0001846B6129SOsmrtm1MtanOsmrtm1MtanOsmrtm1MtanOsmrtm1Mtan
• insulin resistance_Osmr<tm1Mtan>/Osmr<tm1Mtan>
  http://metadb.riken.jp/0005331B6129SOsmrtm1MtanOsmrtm1MtanOsmrtm1MtanOsmrtm1Mtan
• increased circulating free fatty acid level_Osmr<tm1Mtan>/Osmr<tm1Mtan>
  http://metadb.riken.jp/0001554B6129SOsmrtm1MtanOsmrtm1MtanOsmrtm1MtanOsmrtm1Mtan
• impaired glucose tolerance_Osmr<tm1Mtan>/Osmr<tm1Mtan>
  http://metadb.riken.jp/0005293B6129SOsmrtm1MtanOsmrtm1MtanOsmrtm1MtanOsmrtm1Mtan
• adipose tissue inflammation_Osmr<tm1Mtan>/Osmr<tm1Mtan>
  http://metadb.riken.jp/0020386B6129SOsmrtm1MtanOsmrtm1MtanOsmrtm1MtanOsmrtm1Mtan

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased circulating triglyceride level in RBRC02711
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004893
• hepatic steatosis in RBRC02711
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004897
• increased circulating tumor necrosis factor level in RBRC02711
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004906
• increased circulating glucose level in RBRC02711
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004903
• increased epididymal fat pad weight in RBRC02711
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004908
• decreased liver glycogen level in RBRC02711
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004911
• increased circulating leptin level in RBRC02711
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004905
• increased circulating insulin level in RBRC02711
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004896
• increased food intake in RBRC02711
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004913
• increased pancreatic beta cell number in RBRC02711
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004899
• abnormal adipose tissue morphology in RBRC02711
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004892
• increased circulating free fatty acid level in RBRC02711
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004894
• increased liver weight in RBRC02711
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004898
• increased circulating cholesterol level in RBRC02711
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004900
• increased circulating interleukin-10 level in RBRC02711
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004907
• impaired glucose tolerance in RBRC02711
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004901
• increased liver cholesterol level in RBRC02711
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004910
• adipose tissue inflammation in RBRC02711
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1012799
• insulin resistance in RBRC02711
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004902
• increased inflammatory response in RBRC02711
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004895
• increased liver triglyceride level in RBRC02711
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004909
• increased subcutaneous adipose tissue amount in RBRC02711
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004912
• increased susceptibility to diet-induced obesity in RBRC02711
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004904